Does ENCORAFENIB Cause Hypersensitivity? 50 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 50 reports of Hypersensitivity have been filed in association with ENCORAFENIB (BRAFTOVI). This represents 0.6% of all adverse event reports for ENCORAFENIB.
50
Reports of Hypersensitivity with ENCORAFENIB
0.6%
of all ENCORAFENIB reports
5
Deaths
19
Hospitalizations
How Dangerous Is Hypersensitivity From ENCORAFENIB?
Of the 50 reports, 5 (10.0%) resulted in death, 19 (38.0%) required hospitalization, and 6 (12.0%) were considered life-threatening.
Is Hypersensitivity Listed in the Official Label?
Yes, Hypersensitivity is listed as a known adverse reaction in the official FDA drug label for ENCORAFENIB.
What Other Side Effects Does ENCORAFENIB Cause?
Death (1,004)
Off label use (989)
Nausea (758)
Fatigue (685)
Diarrhoea (574)
Neoplasm progression (548)
Pyrexia (539)
Product use in unapproved indication (506)
Vomiting (429)
Rash (414)
What Other Drugs Cause Hypersensitivity?
ETANERCEPT (10,846)
ADALIMUMAB (10,641)
METHOTREXATE (9,799)
TOCILIZUMAB (9,076)
ABATACEPT (8,945)
INFLIXIMAB (8,519)
RITUXIMAB (8,408)
ADAPALENE (8,356)
LEFLUNOMIDE (7,926)
CERTOLIZUMAB PEGOL (7,353)
Which ENCORAFENIB Alternatives Have Lower Hypersensitivity Risk?
ENCORAFENIB vs ENDOXAN
ENCORAFENIB vs ENDOXAN BAXTER
ENCORAFENIB vs ENDOXAN INJ
ENCORAFENIB vs ENDOXAN , POUDRE POUR
ENCORAFENIB vs ENFORTUMAB VEDOTIN